Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

Author： Luo Hong  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.134, Iss.9, 2008-09, pp. : 937-945

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis

By Orlandi L.   Colella G.   Bearzatto A.   Abolafio G.   Manzotti C.   Daidone M.G.   Zaffaroni N.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 649-659

Elsevier

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models

By            

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 957-962

Spandidos Publications

Access to resources Recommend Favorite

HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer

By Wang Yu   Wang Hongli   Song Tiefang   Zou Yiting   Jiang Jing   Fang Lei   Li Peiling  

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-08 ,pp. : 2211-2216

Spandidos Publications

Access to resources Recommend Favorite